Filing Details

Accession Number:
0001127602-21-004183
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-05 16:36:55
Reporting Period:
2021-02-04
Accepted Time:
2021-02-05 16:36:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
313143 Haemonetics Corp HAE Surgical & Medical Instruments & Apparatus (3841) 042882273
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1722327 Dan Goldstein 125 Summer Street
Boston MA 02110
Vp, Corporate Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-04 1,457 $34.21 3,206 No 4 M Direct
Common Stock Disposition 2021-02-04 1,457 $135.84 1,749 No 4 S Direct
Common Stock Acquisiton 2021-02-04 476 $93.52 2,225 No 4 M Direct
Common Stock Disposition 2021-02-04 476 $135.88 1,749 No 4 S Direct
Common Stock Acquisiton 2021-02-04 500 $98.03 2,249 No 4 M Direct
Common Stock Disposition 2021-02-04 500 $135.72 1,749 No 4 S Direct
Common Stock Disposition 2021-02-04 238 $136.26 1,511 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-02-04 1,457 $0.00 1,457 $34.21
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-02-04 476 $0.00 476 $93.52
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-02-04 500 $0.00 500 $98.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-10-25 2023-10-25 No 4 M Direct
952 2019-06-11 2025-06-11 No 4 M Direct
1,503 2020-05-14 2026-05-14 No 4 M Direct
Footnotes
  1. This number includes unvested restricted stock units previously reported.
  2. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.